Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies

Steven W. Pipe, MD, Michael Recht, MD PhD, Nigel S. Key, MD, Frank W.G. Leebeek, MD PhD, Giancarlo Castaman, MD, Susan U. Lattimore, R.N., Paul Van Der Valk, Kathelijne Peerlinck, MD PhD, Michiel Coppens, MD, Niamh O'Connell, MD PhD, John Pasi, MB, ChB, PhD FRCP, FRCPath, FRCPCH, Peter Kampmann, MD, Karina Meijer, MD PhD, Annette von Drygalski, MD Pharm D, Guy Young, MD, Cedric Hermans, MDMRCP,PhD, Jan Astermark, MD PhD, Robert Klamroth, MD PhD, Richard S. Lemons, MD, Nathan Visweshwar, MD, Shelley Crary, MD MS, Rashid Kazmi, MBBS, Emily Symington, Miguel A. Escobar, MD, Esteban Gomez, MD, Rebecca Kruse-Jarres, MD, Adam Kotowski, MD, Doris Quon, MD PhD, Michael Wang, MD, Allison P. Wheeler, MD, Eileen K Sawyer, PhD, Stephanie Verweij, BSc, Valerie Colletta, MSc, Naghmana Bajma, MD, Robert Gut, MD PhD, Wolfgang A. Miesbach, MD PhD

Blood (2020) 136 (Supplement_2): LBA-6.

https://doi.org/10.1182/blood-2020-143560

Published: 2020

Journal Articles

Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study

Katharina Holstein, MD, Andrea Smith, Paul Knöbl, MD PhD, Christiane Dobbelstein, MD, Wolfgang A. Miesbach, MD PhD, Michael Spannagl, MD PhD, Jürgen Heinz, MD PhD, Ute Scholz, MD, Hermann Eichler, MD, Angela Huth-Kühne, MD, Robert Klamroth, MD PhD, Armin Koch, MD PhD, Andreas Tiede, MD

Blood (2017) 130 (Supplement 1): 22.

https://doi.org/10.1182/blood.V130.Suppl_1.22.22

Published: 2017

Journal Articles

Self- and Parent/Proxies-Reported Health-Related Quality Of Life In Children and Adolescents With Bleeding Disorders: Cross Sectional Investigation and Comparison With Healthy Siblings and Healthy Peers

Neuner Bruno, Sylvia von Mackensen, PhD, Susan Halimeh, MD, Susanne Holzhauer, MD, Robert Klamroth, MD, PhD, Karin Kurnik, MD, Anne Kruempel, MD, Michael Fruewald, Henning Krampe, Ulrike Nowak-Goettl

Blood (2013) 122 (21): 4773.

https://doi.org/10.1182/blood.V122.21.4773.4773

Published: 2013

Journal Articles

The Pharmacokinetics Of Turoctocog Alfa Are Consistent Over Different Concentrations and Production Lots

Víctor Jiménez-Yuste, PhD, Sandra Lejniece, PhD, MD, Robert Klamroth, MD, PhD, Trine Saugstrup, Judi Moss

Blood (2013) 122 (21): 4783.

https://doi.org/10.1182/blood.V122.21.4783.4783

Published: 2013

Journal Articles

Prognostic Parameters For Remission Of and Survival In Acquired Hemophilia A: Results Of The GTH-AH 01/2010 Multicenter Study

Andreas Tiede, MD, PhD, Jan-Malte Blumtritt, Robert Klamroth, MD, PhD, Saskia Gottstein, MD, Katharina Holstein, MD, Jürgen Heinz, MD, Rüdiger E. Scharf, MD, PhD, Angela Huth-Kühne, MD, PhD, Joachim F. Schenk, MD, PhD, Richard Greil, MD, Wolfgang A. Miesbach, MD, PhD, Ralf Ulrich Trappe, MD, PhD, Ute Scholz, MD, Daniela Manner, MD, Peter Neumeister, MD, Charis von Auer-Wegener, MD, Ulrich Kalus, MD, Klaus Leimkühler, MD, Paul Knoebl, MD

Blood (2013) 122 (21): 205.

https://doi.org/10.1182/blood.V122.21.205.205

Published: 2013

Journal Articles

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Blood (2011) 118 (21): 2275.

https://doi.org/10.1182/blood.V118.21.2275.2275

Published: 2011

Journal Articles

Sequential Combined Bypassing Therapy (SCBT) Is Safe and Effective in the Treatment of Unresponsive Bleeding in Adults and Children with Haemophilia and Inhibitors.

Alessandro Gringeri, MD, MSc, Kathelijn Fischer, MD, PhD, MSc, Anastasia Karafoulidou, MD, Robert Klamroth, MD, Maria Fernanda Lopez, MD, Maria Elisa Mancuso, MD

Blood (2009) 114 (22): 1294.

https://doi.org/10.1182/blood.V114.22.1294.1294

Published: 2009

Journal Articles

Cardiovascular Interventions in Patients with Hemophilia and Severe Von Willebrand Disease.

Andreas Tiede, MD, PhD, Sonja R. Alesci, MD, Klamroth, MD, Katharina Holstein, MD, Manuela Krause, MD, Ronald Fischer, MD, Ute Scholz, MD, Johannes Oldenburg, MD, Silvia Horneff, MD

Blood (2008) 112 (11): 2281.

https://doi.org/10.1182/blood.V112.11.2281.2281

Published: 2008

Journal Articles

First Census of Patients with Hemophilia a/B and Von Willebrand Disease Type 3 in the Eastern Part of Germany since 1988

Juergen Koscielny, MD, PhD, Ute Scholz, MD, PhD, Robert Klamroth, MD, PhD

Blood (2008) 112 (11): 4532.

https://doi.org/10.1182/blood.V112.11.4532.4532

Published: 2008

Journal Articles

Thrombophilia in Patients with Occlusions of Vascular Bypass Grafts.

Robert Klamroth, MD, Marija Orlovic, Hartmut Rimpler, MD, Helmut Landgraf, MD

Blood (2005) 106 (11): 2156.

https://doi.org/10.1182/blood.V106.11.2156.2156

Published: 2005

Journal Articles

Clopidogrel Resistance and Aspirin Resistance - a Cause of Coronary Artery Stent Thrombosis?.

Robert Klamroth, MD, Stefan Hoffmann, MD, Dietrich Andresen, MD, Helmut Landgraf, MD

Blood (2004) 104 (11): 4070.

https://doi.org/10.1182/blood.V104.11.4070.4070

Published: 2004

Journal Articles

Recurrent Vascular Access Site Thrombosis in Patients on Hemodialysis - a Problem of Thrombophilia?.

Robert Klamroth, MD, Frank Seibt, MD, Hartmut Rimpler, MD, Helmut Landgraf, MD

Blood (2004) 104 (11): 4018.

https://doi.org/10.1182/blood.V104.11.4018.4018

Published: 2004

Journal Articles

Lipoprotein (A) and Further Prothrombotic Risk Factors in Women with Unexplained Recurrent Miscarriage- Results of a Multicenter Case-Control Study.

Ulrike Nowak-Gottl, MD, Barbara Sonntag, MD, Robert Klamroth, MD, Achim Heinecke, MD, Claus Langer, PhD, Inge Scharrer, MD, Robert Greb, MD, Manuela Krause, MD

Blood (2004) 104 (11): 2599.

https://doi.org/10.1182/blood.V104.11.2599.2599

Published: 2004

NARROW

First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies

Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study

Self- and Parent/Proxies-Reported Health-Related Quality Of Life In Children and Adolescents With Bleeding Disorders: Cross Sectional Investigation and Comparison With Healthy Siblings and Healthy Peers

The Pharmacokinetics Of Turoctocog Alfa Are Consistent Over Different Concentrations and Production Lots

Prognostic Parameters For Remission Of and Survival In Acquired Hemophilia A: Results Of The GTH-AH 01/2010 Multicenter Study

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Sequential Combined Bypassing Therapy (SCBT) Is Safe and Effective in the Treatment of Unresponsive Bleeding in Adults and Children with Haemophilia and Inhibitors.

Cardiovascular Interventions in Patients with Hemophilia and Severe Von Willebrand Disease.

First Census of Patients with Hemophilia a/B and Von Willebrand Disease Type 3 in the Eastern Part of Germany since 1988

Thrombophilia in Patients with Occlusions of Vascular Bypass Grafts.

Clopidogrel Resistance and Aspirin Resistance - a Cause of Coronary Artery Stent Thrombosis?.

Recurrent Vascular Access Site Thrombosis in Patients on Hemodialysis - a Problem of Thrombophilia?.

Lipoprotein (A) and Further Prothrombotic Risk Factors in Women with Unexplained Recurrent Miscarriage- Results of a Multicenter Case-Control Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only